高齢者における症
1University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK.
Lancet (London, England)
|May 3, 2000
まとめ
は高齢者に最も多く見られ,しばしば他の病気と関連しています. 効果的な抗薬による治療は,高齢患者の70%で発作をコントロールし,生活の質を向上させることができます.
科学分野:
- ゲリアトリクス ゲリアトリクス
- 神経学 神経学とは
- 公衆衛生は公衆衛生である.
背景:
- エピレプシの流行と発症率は,高齢者の新症例の約25%で,後年期のピークに達します.
- エピレプシーを持つ多くの高齢者は,同時に発生する神経退行性,脳血管性,または腫瘍性疾患を持っています.
- 発作の予測不可能な性質は,診断の受け入れ,自信の喪失,および独立性の困難につながる可能性があります.
研究 の 目的:
- 高齢者におけるエピレプシーの課題と最適な管理戦略を強調する.
- 発作が遅発した発作障害が医療システムと医療費に及ぼす影響を強調する.
- エピレプシーを患っている高齢者の生活の質を改善するために,連携したヘルスケアプログラムを提唱する.
主な方法:
- 高齢者のエピレプシーに関する疫学データのレビュー.
- 抗薬による治療結果の分析.
- エピレプシーの医療資源への影響の評価
主要な成果:
- 抗薬による治療を受けた高齢患者の約70%で完全な発作制御が可能である.
- 高齢者における発作は,身体的傷害と精神的な低下につながる可能性があります.
- 高齢期のエピレプシーの出現は,医療施設の負担と関連する費用を増加させます.
結論:
- 最適な管理には,迅速な調査,正確な診断,効果的な治療,支援的な患者教育が必要です.
- 医療従事者の間で連携したアプローチは,独立性を維持し,この脆弱なグループの生活の質を向上させるために不可欠です.
- 遅発性の治療は,医療負担を管理し,患者の治療結果を改善するために不可欠です.
関連する概念動画
The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


